Lataa...
Real-world impact of granulocyte-colony stimulating factor on febrile neutropenia
BACKGROUND: Primary prophylaxis with granulocyte colony–stimulating factors (pp-g-csf) is recommended in patients undergoing chemotherapy carrying a febrile neutropenia (fn) risk of 20% or more. In the present study, we examined clinical practice patterns and the impact of pp-g-csf on fn incidence i...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Multimed Inc.
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3671024/ https://ncbi.nlm.nih.gov/pubmed/23737687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.20.1306 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|